Tolperisone

DB06264InvestigationalSmall molecule

Tolperisone is a muscle relaxant used to relieve spasticity after stroke in adults. Its precise mechanism is not completely understood, though it blocks sodium and calcium channels.

Chemical structure of Tolperisone
Primary indication
Investigated for use/treatment in neurologic disorders, spinal cord injuries, muscle spasm, back pain, and multiple sclerosis.Curator reviewed · 1 structured indication
Formula / weight
C16H23NO · 245.366 g/mol (avg)
Code names
AV650 · SPH-3047

Resolves to

Compound
UNIIF5EOM0LD8ECAS728-88-1ChEMBLCHEMBL1076211ChEBI93835KEGGD08617
Clinical / RWD
RxNorm10639ATCM02AX06ATCM03BX04
Structure
InChIKeyFSKFPVLPFLJRQB-UHFFFAOYSA-NSMILESCC(CN1CCCCC1)C(=O)C1=CC=C(C)C=C1
Targets
Q9UI33SCN11A

What you can answer from here — as of September 16, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
671Drug interactionsStructured to mechanism, not free text
Sign in
8Clinical trialsPhase, status and sponsor resolved per trial
Sign in
1Structured indicationCondition, population, route and combination as fields, not prose
Sign in
3ContraindicationsEach with its own population and attribute set
Sign in
79Marketed productsAcross 3 countries and 19 labellers
Sign in
2ATC codesIncluding every combination product, plus 13 drug categories
Sign in
2+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with Tolperisone, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In